CStone Pharmaceuticals has announced the appointment of Ms. Catherine Yen as an independent non-executive director, effective January 21, 2026. Ms. Yen will also serve as chairperson of the Compensation Committee and as a member of the Audit Committee and the Nomination Committee. She succeeds Mr. Wu, who has resigned from these roles.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CStone Pharmaceuticals published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260121-11997551), on January 21, 2026, and is solely responsible for the information contained therein.